Attached herewith Letter of Offer dated July 23, 2025 received by the Company.

Open Offer TriggeredListed Co AcquisitionStrategic Transactions View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.4%Reaction day

₹65.60

prior close

₹67.00

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.9%+3.3% vs market

Pharmaceuticals peers, median of 149sector-1.0%+2.3% vs sector

On the reaction day the stock moved 3.3 pts more than Nifty Microcap 250 and 2.3 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

-0.1

30m

-0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.4-1.9+3.3-1.0+2.3

Next day

-0.6-3.1+2.5-1.7+1.1

-0.9-1.6+0.7-0.8-0.2

-0.9-1.3+0.4-0.7-0.2

-2.6-2.0-0.6-1.5-1.1

-3.9-3.6-0.3-3.6-0.3

-4.7-3.4-1.3-3.3-1.4

15d

-4.9-4.0-0.8-4.8-0.0

-4.9-3.4-1.5-4.5-0.3

-6.3-3.1-3.2-4.7-1.6

-22.3-2.8-19.5-7.9-14.4

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 149Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Pharmaids Pharmaceuticals has received the Letter of Offer dated July 23, 2025 for a mandatory open offer triggered by a Share Purchase Agreement signed on December 27, 2024. The acquirer is Shankarappa Nagaraja Vinaya Babu, acting along with Tumkur Trade Center Private Limited. The offer is to buy up to 91,69,632 equity shares (26% of voting capital) from public shareholders at ₹62.15 per share, totalling about ₹56.99 crore. The underlying SPA was for just 3,27,085 shares (0.93%) at ₹35 per share, which is what triggered the mandatory open offer. The tendering window opens on August 4, 2025 and closes on August 18, 2025. If fully accepted, the acquirer group would end up holding about 51.28% of the company, resulting in a change of control. The acquirer has also already extended a ₹7 crore loan to the company for operations.

Likely market impact

Public shareholders can tender their shares at ₹62.15 each during the August 4–18 window. The offer signals an impending change of control, with the acquirer and PAC set to cross the 50% threshold post-offer, which may affect minority shareholders and future strategic decisions.